This research explores how gold-silver sulfide nanoparticles exhibit strong NIR-II emission, suggesting promising targeted therapy applications in cancer and bacterial infections.
Janus nanoparticles (JNPs) represent one of the most complex nanoparticles, and achieving precise control over their synthesis remains a significant challenge. Here, we explore gold-silver sulfide (Au-Ag₂S) JNPs for targeted anticancer and antibacterial therapies. Au-Ag₂S JNPs were synthesized and characterized using TEM, HRTEM, XRD, EDS, and XPS, confirming their distinct dimeric structure with Au and Ag₂S components. Surface modification with DSPE-PEG and folic acid (FA) enhanced stability and enabled targeted delivery to cancer cells, resulting in AADF JNPs. AADF JNPs exhibited strong NIR-II emission, ideal for in vivo imaging and photothermal therapy (PTT). In vitro studies demonstrated high biocompatibility and enhanced cellular uptake in 4T1 cancer cells compared to non-targeted JNPs. Upon laser irradiation, AADF JNPs effectively reduced 4T1 cell viability, demonstrating their phototherapeutic effect. Furthermore, AADF JNPs exhibited potent antibacterial activity against Escherichia coli and Staphylococcus aureus under NIR irradiation, it achieved 78% tumor cell killing and 99% bacterial eradication. These findings highlight the potential of AADF JNPs as a promising solution for targeted cancer and bacterial infection treatments.
No takes yet. Share an insight, caveat, or question.
Long et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: